Navigation Links
Texas Biotech Firms Receive More Than $35 Million in Federal Grants and Credits
Date:11/4/2010

AUSTIN, Texas, Nov. 4, 2010 /PRNewswire/ -- One-hundred seventeen Texas biotechnology companies were awarded more than $35 million in federal tax credits and grants yesterday as part of the Qualifying Therapeutic Discovery Project Tax Credit Program administered by the U.S. Department of the Treasury and the National Institutes of Health.

"The Therapeutic Discovery Credit has provided Texas Life Science companies the ability to continue to invest resources into their ongoing research and development activities," said Tom Kowalski, President of the Texas Healthcare and Bioscience Institute (THBI).  "This comes in the form of equipment and personnel.  This tax credit provides a much needed shot in the arm for Texas Life Science Companies to help them weather the tight credit markets."  

The announcement of the awards was made yesterday in Washington, D.C. by Secretary of the Treasury Tim Geithner and Secretary of Health and Human Services Kathleen Sebelius who were also joined by NIH Director Dr. Francis Collins to announce the recipients of the $1 billion in new therapeutic discovery project credits.

"These grants made possible by the Affordable Care Act will not only help to create jobs and bolster the economy but also bring us closer to the next generation of life-saving cures," said NIH Director Dr. Francis Collins.  "The projects funded show significant potential to create new therapies that will address unmet medical needs and bolster the medical countermeasure supply we use to respond to health emergencies."

A total of 2,923 companies specializing in biotechnology and medical research in 47 states and the District of Columbia received awards under the program.  In all, 4,606 applications from these nearly 3,000 companies were awarded funding.

The therapeutic discovery project program is targeted to projects that show significant potential to produce new therapies, address unmet medical needs, reduce the long-term growth of health care costs, or advance the goal of curing cancer within the next 30 years.  The allocation of the credit also reflects which projects show the greatest potential to create and sustain high-quality, high-paying jobs in the United States and to advance our competitiveness in the fields of life, biological, and medical sciences.  Today, the biotechnology industry employs 1.3 million workers, and the industry continues to be a key growth engine for the economy.

The credit covers up to 50 percent of the cost of qualifying biomedical research and is only available to firms with fewer than 250 employees.  To provide an immediate boost to U.S. biomedical research and the small businesses that conduct it, the credit is effective for investments made in 2009 and 2010.  Firms could opt to receive a grant instead of a tax credit, so start-ups that are not yet profitable can benefit as well.

In Texas, a total of 158 projects at 117 companies will receive over $35 million in funding through the program.  Several companies were awarded for multiple projects, with eleven being the highest number of awards given to a single company in Texas.

According to THBI, the Texas Life Science industry generates a significant economic impact in the State of Texas.  The total economic impact in Texas is estimated at $75 Billion in economic activity, 236,000 jobs and $31 Billion in payroll.  State and local governments receive and estimated $2 Billion each year due to these impacts.  

The Biotechnology Industry Organization (BIO), supported by more than 40 state bioscience affiliate organizations, was instrumental in advocating for the program and is now encouraging policy-makers to renew the program for another year.  Jim Greenwood, president and CEO of BIO said, "We now call on Congress and the Administration to work together to extend and expand the Therapeutic Discovery Project to support continued American innovation and accelerate the development of life-saving cures."

To view the full list, click here.

The mission of the Texas Healthcare and Bioscience Institute is to research, develop, and advocate policies and actions that promote biomedical science, biotechnology, agriculture and medical device innovation in Texas.   www.thbi.com


'/>"/>
SOURCE Texas Healthcare & Bioscience Institute
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Texas A&M chemical engineers work could lead to improved DNA analysis
2. Texas A&M veterinary researchers achieve cloning first
3. Texas Tech, U of Utah win Sandia microdevice competition
4. Texas Teen Opts for Stem Cell Therapy, Hopes of Enlisting in Military
5. $250,000 Awarded to Smartfield, Inc. of Lubbock, TX by the Texas Emerging Technology Fund
6. Texas-Based Consortium Announces Project GreenVax: A Groundbreaking Vaccine Manufacturing Research Program
7. UH Superconductivity Center Receives Texas Emerging Technology Fund Award
8. WaferGen Announces that University of Texas Southwestern Medical Center Demonstrates Utility of New SmartChip(TM) Nano-Dispenser with WaferGens SmartChip(TM) High-throughput Real-Time PCR System
9. Texas State University Prepares for Phase 2 Research on the Potential New Cancer and HIV Fighting ALKA-V6 Compound
10. SRA International Wins $16 Million Contract from Cancer Prevention and Research Institute of Texas
11. University of Texas Picosatellite to be launched from space shuttle to begin milestone mission
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 /PRNewswire/ ... London (ICR) and University of ... tool to risk-stratify patients with multiple myeloma (MM), in a ... . The University of Leeds is ... Myeloma UK, and ICR will perform the testing services to ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive ... a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM ... firm for the life sciences and healthcare industries, announces a presentation by Subbu ... , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a ...
(Date:10/9/2017)... ... October 09, 2017 , ... The Giving Tree ... products targeting the needs of consumers who are incorporating medical marijuana into their ... Phoenix, Arizona. , As operators of two successful Valley dispensaries, The Giving Tree’s ...
Breaking Biology Technology:
(Date:10/4/2017)... , Oct. 4, 2017  GCE Solutions, a global clinical research ... and document anonymization solution on October 4, 2017. Shadow is designed ... to comply with policy 0070 of the European Medicines Agency (EMA) ... ... Solutions ...
(Date:6/23/2017)... ITHACA, N.Y. , June 23, 2017  IBM ... in dairy research, today announced a new collaboration using ... the chances that the global milk supply is impacted ... project, Cornell University has become the newest academic institution ... Chain, a food safety initiative that includes IBM Research, ...
(Date:5/6/2017)... , May 5, 2017 RAM ... announced a new breakthrough in biometric authentication based ... quantum mechanical properties to perform biometric authentication. These new ... semiconductor material created by Ram Group and its ... entertainment, transportation, supply chains and security. Ram Group ...
Breaking Biology News(10 mins):